載入中
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.
前收盤價
US$2.72
+US$0.06 · +2.26%
盤中時間採用ET。市場資料可能有所延遲。
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.
日內區間
目前US$2.72
52週區間
目前US$2.72
盤中時間採用ET。市場資料可能有所延遲。
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.
日內區間
目前US$2.72
52週區間
目前US$2.72
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 銷貨成本 | 167.2萬 USD | — | — | — | — |
| 毛利 | −167.2萬 USD | — | — | — | — |
| 研究與開發 | 1997.3萬 USD | 1469.7萬 USD | 1288萬 USD | 906.2萬 USD | 772.92萬 USD |
| 銷售、一般及管理費用 | 758.7萬 USD | 435.1萬 USD | 464.9萬 USD | 481.6萬 USD | 719.72萬 USD |
| 營業費用 | 2588.8萬 USD | 1904.8萬 USD | 1752.9萬 USD | 1387.8萬 USD | 1492.64萬 USD |
| 利息支出 | — | — | — | — | 275.22萬 USD |
| 折舊和攤銷 | 167.2萬 USD | 106.3萬 USD | 42.6萬 USD | 15.2萬 USD | 11.75萬 USD |
| 營業利益 | −2756萬 USD | −1904.8萬 USD | −1752.9萬 USD | −1387.8萬 USD | −1492.64萬 USD |
| 淨利 | −2824.2萬 USD | −1882.4萬 USD | −1747萬 USD | −1387.9萬 USD | −1863.28萬 USD |
公司資料更新於 2026年10月11日。
第三方分析師預期可能變動，並非 GoAI 建議。
評級樣本有限，僅3項
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
